Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Bolus Versus Continuous Cefazolin Infusion in Major Surgery
NCT02058979Completed
- Sponsor
- University of Virginia
- Start
- Nov 2014
- Primary completion
- Jun 2016
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
Randomised, open-label trial of cefazolin in surgical site infection (SSI) (2 arms), sponsored by University of Virginia. Primary endpoint: Plasma Concentration of Antibiotics at 1 day. Started Nov 2014; status: completed.
02
Drugs
cefazolin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT02058979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02058979.